Pancreatic diseases remain an important area for pharmaceutical research and therapeutic management. Drug development is addressing digestive enzyme deficiencies, inflammatory conditions, and other pancreatic complications. Increasing clinical attention to early intervention is creating opportunities for more specialized treatment strategies. The Digestive System Drugs Market was valued at US$...